Guidelines The introduction of nucleic acid amplification technology (NAT) for the detection of hepatitis C virus RNA in plasma pools (addendum to note for guidance on plasma- derived medicinal products)
Linee guida The introduction of nucleic acid amplification technology (NAT) for the detection of hepatitis C virus RNA in plasma pools (addendum to note for guidance on plasma-derived medicinal products)